Traci Green, PhD, MSc

Traci Green, is an epidemiologist whose research focuses on drug use, opioid use disorder, and drug-related injury. She earned a Master of Science in Epidemiology and Biostatistics from McGill University and a PhD in Epidemiology from Yale University. Dr. Green is currently Professor and Director of the Opioid Policy Research Collaborative at the Heller School for Social Policy and Management at Brandeis University.  Previously she served as Deputy Director of the Boston Medical Center Injury Prevention Center, Associate Professor of Emergency Medicine and Community Health Sciences at the Boston University Schools of Medicine and Public Health. She is an Adjunct Associate Professor at the Warren Alpert School of Medicine at Brown University where she co-directs the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital.

A person with blonde hair smiling

Description automatically generatedDr. Green helped co-found www.prescribetoprevent.org for prescribers and pharmacists and its companion site www.prevent-protect.org for families, patients, and community organizations. She helped design the ASI-MV®, a real-time illicit and prescription drug abuse surveillance system developed by Inflexion, Inc. Her current work advances consumer safety for people who use drugs through preventive interventions, drug checking and monitoring of the illicit drug supply.  She serves as an expert advisor to the Rhode Island Governor on addiction and overdose and consults for the Center for Disease Control and Prevention and the High Intensity Drug Trafficking Areas on public health and public safety opportunities. She served on the Board of Scientific Counselors for the CDC’s National Center for Injury Prevention and Control and two recent National Academy of Sciences, Engineering, and Medicine’s Committees pertaining to opioid pain management, regulatory strategies to address opioids, and medications for opioid use disorder. Her research is supported by the CDC, the National Institute on Drug Abuse, the Agency for Healthcare Research and Quality, the Patient Centered Outcomes Research Institute, the Bloomberg American Health Initiative, the RIZE Foundation, and the Department of Justice.